Overview

eotaxin


'eotaxin' can also refer to...

eotaxin

eotaxin

Eotaxin contributes to renal interstitial eosinophilia.

Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis

Diagnosis of Churg–Strauss syndrome: eotaxin-3 makes it easier

Control of extravillous trophoblast function by the eotaxins CCL11, CCL24 and CCL26

Eotaxin-3 in Churg–Strauss syndrome: a clinical and immunogenetic study

Eotaxin Expression in Onchocevca volvulus-Induced Dermatitis after Topical Application of Diethylcarbamazine

N-terminal domain of eotaxin-3 is important for activation of CC chemokine receptor 3

Th1-derived cytokine IFN-γ is a potent inhibitor of eotaxin synthesis in vitro

Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade

Association of Eotaxin gene family with asthma and serum total IgE

Association of Eotaxin gene family with asthma and serum total IgE

Association between plasma levels of eotaxin (CCL-11) and treatment response to interferon-α and ribavirin in HIV/HCV co-infected patients

Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions

In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction

Eosinophils in the human corpus luteum: the role of RANTES and eotaxin in eosinophil attraction into periovulatory structures

Eotaxin-3 is involved in Churg–Strauss syndrome – a serum marker closely correlating with disease activity

 

More Like This

Show all results sharing these subjects:

  • Medicine and Health
  • Chemistry

GO

Show Summary Details

Quick Reference

A chemokine (CCL11, 97 aa), originally described as being eosinophil-specific but subsequently shown to attract IL-2- and IL-4-stimulated T cells which, unlike naive T cells, express the CCR3 chemokine receptor.

Subjects: Medicine and Health — Chemistry.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.